Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Bladder Cancer

  Free Subscription


1 Adv Anat Pathol
2 Anticancer Res
1 Biochem Biophys Res Commun
1 BJU Int
1 BMC Cancer
1 Br J Radiol
1 Clin Cancer Res
1 Drug Dev Ind Pharm
2 Eur Urol
1 Histol Histopathol
1 J Clin Oncol
1 J Comp Pathol
1 Korean J Parasitol
1 Med Oncol
1 Mol Cell Biochem
1 N Engl J Med
2 Nat Rev Dis Primers
1 Oncol Rep
1 Oncology
1 Oncotarget
2 PLoS One
1 Proc Inst Mech Eng H
1 Scand J Urol
2 Urol Int
2 Urol J
1 Urol Oncol
2 World J Urol

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Adv Anat Pathol

  1. PANER GP, Montironi R, Amin MB
    Challenges in Pathologic Staging of Bladder Cancer: Proposals for Fresh Approaches of Assessing Pathologic Stage in Light of Recent Studies and Observations Pertaining to Bladder Histoanatomic Variances.
    Adv Anat Pathol. 2017;24:113-127.
    PubMed     Text format     Abstract available

    Anticancer Res

  2. HUDOLIN T, Mengus C, Coulot J, Kastelan Z, et al
    Expression of Indoleamine 2,3-Dioxygenase Gene Is a Feature of Poorly Differentiated Non-muscle-invasive Urothelial Cell Bladder Carcinomas.
    Anticancer Res. 2017;37:1375-1380.
    PubMed     Text format     Abstract available

  3. SHI CS, Li JM, Chin CC, Kuo YH, et al
    Evodiamine Induces Cell Growth Arrest, Apoptosis and Suppresses Tumorigenesis in Human Urothelial Cell Carcinoma Cells.
    Anticancer Res. 2017;37:1149-1159.
    PubMed     Text format     Abstract available

    Biochem Biophys Res Commun

  4. LI Y, Wen JM, Du CJ, Hu SM, et al
    Thymol inhibits bladder cancer cell proliferation via inducing cell cycle arrest and apoptosis.
    Biochem Biophys Res Commun. 2017 Apr 4. pii: S0006-291X(17)30666.
    PubMed     Text format     Abstract available

    BJU Int

  5. HAYNE D, Stockler M, McCombie SP, Lawrence N, et al
    The BCG + Mitomycin trial for high risk non-muscle-invasive bladder cancer: Progress report and lessons learned.
    BJU Int. 2017 Apr 9. doi: 10.1111/bju.13873.
    PubMed     Text format     Abstract available

    BMC Cancer

  6. LAVERY HJ, Zaharieva B, McFaddin A, Heerema N, et al
    A prospective comparison of UroVysion FISH and urine cytology in bladder cancer detection.
    BMC Cancer. 2017;17:247.
    PubMed     Text format     Abstract available

    Br J Radiol

  7. SHARMA A, Mete UK, Sood A, Kakkar N, et al
    Utility of early dynamic and delayed post-diuretic 18F-FDG PET/CT SUVmax in predicting tumor grade and T-stage of urinary bladder carcinoma: Results from a prospective single center study.
    Br J Radiol. 2017 Mar 3:20160787. doi: 10.1259/bjr.20160787.
    PubMed     Text format     Abstract available

    Clin Cancer Res

  8. YANG L, Taylor J, Eustace A, Irlam J, et al
    A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High Risk Bladder Cancer Patients.
    Clin Cancer Res. 2017 Apr 11. pii: clincanres.0038.2017.
    PubMed     Text format     Abstract available

    Drug Dev Ind Pharm

  9. WANG LH, Lei S, Dong Yuan S, Che X, et al
    Long-term floating control-released intravesical preparation of 5-fluorouracil for the local treatment of bladder cancer.
    Drug Dev Ind Pharm. 2017 Apr 12:1-21. doi: 10.1080/03639045.2017.1318898.
    PubMed     Text format     Abstract available

    Eur Urol

  10. SEILER R, Ashab HA, Erho N, van Rhijn BW, et al
    Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.
    Eur Urol. 2017 Apr 5. pii: S0302-2838(17)30251.
    PubMed     Text format     Abstract available

  11. SEILER R, Oo HZ, Tortora D, Clausen TM, et al
    An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer.
    Eur Urol. 2017 Apr 10. pii: S0302-2838(17)30232.
    PubMed     Text format     Abstract available

    Histol Histopathol

  12. GUO S, Fan C, Rohr J, Fan L, et al
    A clinicopathologic study of paragangliomas of the urinary bladder: can the clinical behavior of the tumor be predicted?
    Histol Histopathol. 2016;31:785-91.
    PubMed     Text format     Abstract available

    J Clin Oncol

  13. KULKARNI GS, Hermanns T, Wei Y, Bhindi B, et al
    Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
    J Clin Oncol. 2017 Apr 14:JCO2016692327. doi: 10.1200/JCO.2016.69.2327.
    PubMed     Text format     Abstract available

    J Comp Pathol

  14. SHRADER S, Lauridson J, King Z, Loch J, et al
    Urachal Adenocarcinoma in a Dog.
    J Comp Pathol. 2016;154:304-8.
    PubMed     Text format     Abstract available

    Korean J Parasitol

  15. CHALA B, Choi MH, Moon KC, Kim HS, et al
    Development of Urinary Bladder Pre-Neoplasia by Schistosoma haematobium Eggs and Chemical Carcinogen in Mice.
    Korean J Parasitol. 2017;55:21-29.
    PubMed     Text format     Abstract available

    Med Oncol

  16. KUSAKA A, Hatakeyama S, Hosogoe S, Hamano I, et al
    Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.
    Med Oncol. 2017;34:90.
    PubMed     Text format     Abstract available

    Mol Cell Biochem

  17. AI XL, Chi Q, Qiu Y, Li HY, et al
    Gap junction protein connexin43 deregulation contributes to bladder carcinogenesis via targeting MAPK pathway.
    Mol Cell Biochem. 2017;428.
    PubMed     Text format     Abstract available

    N Engl J Med

  18. DAVIES BJ, Hwang TJ, Kesselheim AS
    Ensuring Access to Injectable Generic Drugs - The Case of Intravesical BCG for Bladder Cancer.
    N Engl J Med. 2017;376:1401-1403.
    PubMed     Text format    

    Nat Rev Dis Primers

  19. SANLI O, Dobruch J, Knowles MA, Burger M, et al
    Bladder cancer.
    Nat Rev Dis Primers. 2017;3:17022.
    PubMed     Text format     Abstract available

  20. Bladder cancer.
    Nat Rev Dis Primers. 2017;3:17023.
    PubMed     Text format    

    Oncol Rep

  21. BA M, Cui S, Wang B, Long H, et al
    Bladder intracavitary hyperthermic perfusion chemotherapy for the prevention of recurrence of non-muscle invasive bladder cancer after transurethral resection.
    Oncol Rep. 2017;37:2761-2770.
    PubMed     Text format     Abstract available


  22. NIEDERSUSS-BEKE D, Puntus T, Kunit T, Grunberger B, et al
    Neoadjuvant Chemotherapy with Gemcitabine plus Cisplatin in Patients with Locally Advanced Bladder Cancer.
    Oncology. 2017 Apr 12. doi: 10.1159/000463389.
    PubMed     Text format     Abstract available


  23. ZHAO L, Tian X, Duan X, Ye Y, et al
    Association of body mass index with bladder cancer risk: a dose-response meta-analysis of prospective cohort studies.
    Oncotarget. 2017 Mar 30. doi: 10.18632/oncotarget.16722.
    PubMed     Text format     Abstract available

    PLoS One

  24. HORI S, Miyake M, Tatsumi Y, Onishi S, et al
    Topical and systemic immunoreaction triggered by intravesical chemotherapy in an N-butyl-N-(4-hydroxybutyl) nitorosamine induced bladder cancer mouse model.
    PLoS One. 2017;12:e0175494.
    PubMed     Text format     Abstract available

  25. LI M, Wang L
    The Associations of Psychological Stress with Depressive and Anxiety Symptoms among Chinese Bladder and Renal Cancer Patients: The Mediating Role of Resilience.
    PLoS One. 2016;11:e0154729.
    PubMed     Text format     Abstract available

    Proc Inst Mech Eng H

  26. BARNES SC, Shepherd DE, Espino DM, Bryan RT, et al
    Design of an improved surgical instrument for the removal of bladder tumours.
    Proc Inst Mech Eng H. 2016;230:579-87.
    PubMed     Text format     Abstract available

    Scand J Urol

  27. PATSCHAN O, Holmang S, Hosseini A, Jancke G, et al
    Second-look resection for primary stage T1 bladder cancer: a population-based study.
    Scand J Urol. 2017 Apr 11:1-7. doi: 10.1080/21681805.2017.1303846.
    PubMed     Text format     Abstract available

    Urol Int

  28. GAKIS G, Efstathiou JA, Daneshmand S, Keegan KA, et al
    Oncological Outcomes of Patients with Concomitant Bladder and Urethral Carcinoma.
    Urol Int. 2016;97:134-41.
    PubMed     Text format     Abstract available

  29. D''AGOSTINO D, Racioppi M, Pugliese D, Ragonese M, et al
    Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up.
    Urol Int. 2016;97:54-60.
    PubMed     Text format     Abstract available

    Urol J

  30. LEMBO F, Subba E, Lagana AS, Vitale SG, et al
    Intradiverticular Sarcomatoid Carcinoma of The Bladder: An Overview Starting From A Peculiar Case.
    Urol J. 2016;13:2800-2.
    PubMed     Text format    

  31. WU SW, Liou JH, Yeh KT, Hung TW, et al
    The Prevalence and Prognostic Significance of Polyomavirus Infection in Patients with Urothelial Carcinoma of the Bladder.
    Urol J. 2016;13:2773-8.
    PubMed     Text format     Abstract available

    Urol Oncol

  32. MALMSTROM PU, Hemdan T, Segersten U
    Validation of the ezrin, CK20, and Ki-67 as potential predictive markers for BCG instillation therapy of non-muscle-invasive bladder cancer.
    Urol Oncol. 2017 Apr 4. pii: S1078-1439(17)30110.
    PubMed     Text format     Abstract available

    World J Urol

  33. COMBERG D, Gauer A, Tschernig T
    First findings of gap junction proteins in human urothelial carcinoma.
    World J Urol. 2016;34:145-7.
    PubMed     Text format    

  34. NOVOTNY V, Froehner M, Koch R, Zastrow S, et al
    Age, American Society of Anesthesiologists physical status classification and Charlson score are independent predictors of 90-day mortality after radical cystectomy.
    World J Urol. 2016;34:1123-9.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.